Artivion (AORT) Acquisitions (2012 - 2020)

Artivion (AORT) posted Acquisitions of -$524000.0 for Q4 2020, up 99.42% on a QoQ basis from -$89.9 million in Q3 2016.

Artivion (AORT) Acquisitions (2012 - 2020) Analysis & Trends

Artivion's Acquisitions history runs 3 years deep, the most recent figure standing at -$524000.0 for Q4 2020.

Quarterly Acquisitions changed N/A year-over-year to -$524000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$90.4 million (changed N/A YoY) and the FY2020 annual result came in at $59.1 million, changed N/A from the prior year.
Acquisitions was -$524000.0 for Q4 2020 at Artivion, up from -$89.9 million in the prior quarter.
Across five years, Acquisitions topped out at $91.2 million in Q1 2016 and bottomed at -$89.9 million in Q3 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	183.17 Bn	175.87 Bn	6.27 Bn	-
2	Stryker	129.06 Bn	126.18 Bn	3.81 Bn	22.00 Mn
3	Medtronic	108.35 Bn	99.13 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	68.56 Bn	67.10 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	48.33 Bn	44.66 Bn	1.29 Bn	-
6	Dexcom	28.38 Bn	27.26 Bn	750.30 Mn	-
7	GE HealthCare Technologies	28.08 Bn	25.80 Bn	1.98 Bn	2.30 Bn
8	Smith & Nephew	26.93 Bn	26.36 Bn	-	-
9	Koninklijke Philips	24.06 Bn	20.93 Bn	2.07 Bn	-268.10 Mn
10	Artivion	1.26 Bn	1.20 Bn	75.45 Mn	-

Download Data